A Singapore group of public healthcare institutions has developed an automated low vision aid system for Aged-related Macular Degeneration (AMD) patients.
AMD is a common degenerative condition of aging that causes damage to the macula and affects central vision resulting in low vision. Patients with AMD may have symptoms such as blurred vision or visual distortion. Assistive low vision aid (ALVA), an automated low vision aid system is proposed to automatically capture real time video image from the user’s perspective and enhance them based on the patient’s needs. This technology aims to overcome the limitation of current low vision aids. It provides patients with automatic assistance in eccentric fixation, distortion correction, vision enhancement and magnification. Current state-of-the-art devices are usually implanted into the eyeballs or of fixed magnification. The ability to respond to change is minimal. ALVA allows the users to control its various aspects using voice commands. Features such as eccentric fixation and distortion correction are not available in the market.
The organization is seeking license/technology and research cooperation with partners of any type from the healthcare industry. The role of the partner would be to either commercialise the technology to bring to market or to further develop this technology to meet the demand-driven needs of the addressable market.
If you are interested in finding out more about this opportunity, please contact Mike Brown, quoting the reference number TOSG20160929001.